- recruitingPHASE1, PHASE2
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
This study is testing a new medicine, STP938, for adults with specific types of lymphoma (blood cancer) that have come back after previous treatments. It aims to find a safe dose and see how well it works in different kinds of B-cell and T-cell lymphomas.
United States · France · United Kingdom - recruitingPHASE1, PHASE2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
This study is testing a new medicine, Tulmimetostat, for people with advanced cancers like solid tumours and lymphomas. It's looking at how safe it is, any side effects, and if it helps to shrink tumours.
United States · France · Italy